global view constructed of white lines

Blog

After Cushing's disease surgery at Pacific Neuroscience Institute
June 8, 2021

Treatment for a Benign Pituitary Tumor Gives Woman Her Life — and Body — Back

by Guest Author

Maple didn’t know what was happening to her. A resident of Hong Kong in her mid-20s, she suffered from frequent headaches, easy bruising, thinning hair and irregular periods. Maple blamed work-related stress and quit her job. But the symptoms persisted. Then her blood pressure started...

Neurodiagnostic Treatment Suite at Pacific Neuroscience Institute
May 28, 2021

Neurodiagnostic Treatment Suite at Pacific Neuroscience Institute

by Zara Jethani

The Pacific Neuroscience Institute’s state-of-the-art Neurodiagnostic Treatment Suite is complete and providing infusion therapies for a variety of neurological conditions including Multiple Sclerosis (MS) and pituitary disorders such as Pituitary Adenomas. Launched in April 2021, the facility represents another convenience for our patients where they...

Castle Connolly 2021 Top doctors
May 14, 2021

PNI Experts Are 2021 Castle Connolly Top Doctors

by Zara Jethani

The Castle Connolly Top Doctor rigorous selection process is entirely merit-based. For 25 years, Castle Connolly’s mission has been to help people find the best healthcare by connecting patients with best-in-class healthcare providers. They provide an unbiased directory of healthcare providers. Through their extensive research...

Los Angeles Magazine Top Doctors 2021
April 9, 2021

Pacific Neuroscience Institute Physicians Named “L.A.’s Top Doctors” of 2021

by Zara Jethani

This year, seven of Pacific Neuroscience Institute Medical Group’s physicians were included in Los Angeles Magazine’s April 2021 roster of “L.A.’s Top Doctors.” The results were based on a Los Angeles Magazine survey that asked physicians throughout Los Angeles County to identify the doctors they considered to be...

Sharmyn McGraw holding the book she authored
April 2, 2021

Cushing’s Disease Helped Shape My Wonderful Life

by Sharmyn McGraw

Now twenty-one years in remission from a pituitary adenoma tumor, Sharmyn McGraw, patient advocate, author, artist, and so much more, talks about the pivotal role of Cushing’s disease in her life. From dyslexia to writer and everything in between. Dealing with a life threatening disease,...

PNI 2021
January 1, 2021

PNI Founders’ Message 2021

by Guest Author

Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.

November Clinical Trials at PNI
December 2, 2020

Clinical Trials Round-Up: December 2020

by Mini Gill

New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A...

November Clinical Trials at PNI
November 2, 2020

Clinical Trials Round-Up: November 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Clinical Trials Round Up October 2020 Cover
October 2, 2020

Clinical Trials Round-Up: October 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Clinical Trials August 2020 Cover
September 1, 2020

Clinical Trials Round-Up: September 2020

by Mini Gill

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience ( PDF ): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma ( NCT03463265 ) Orbus Therapeutics ( PDF ): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Last updated: February 23rd, 2021